Oncoshot today announced a pre-series A funding round led by MassMutual Ventures (MMV). Other investors for this stage come from a suite of healthtech veterans that include Milltrust International and health industry angel investors.

Oncoshot was founded in 2018 by Dr Huren Sivaraj, a medical oncologist, and Ruslan Enikeev, a data science engineer. Oncoshot's mission is to help oncologists identify cancer clinical trials more efficiently and effectively for patients and their caregivers by supporting hospitals and research partners. Its current focus is to leverage artificial intelligence technology to address the inefficiencies of cancer clinical trials. Oncoshot has expanded to Australia and India since its inception in Singapore, an act that highlights its applicability and success. For more information, visit https://www.oncoshot.com/.

https://www.oncoshot.com/

Oncoshot Receives Funding To Expand Cancer Data Sharing Capabilities For Hospitals And Industry

Description

Company Information

Oncoshot Receives Funding To Expand Cancer Data Sharing Capabilities For Hospitals And Industry

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Company Information